A NOVEL INTRAGENIC DELETION RELATED TO THE ARGININE VASOPRESSIN V2 RECEPTOR CAUSES NEPHROGENIC DIABETES INSIPIDUS
- PMID: 33363649
- PMCID: PMC7748242
- DOI: 10.4183/aeb.2020.295
A NOVEL INTRAGENIC DELETION RELATED TO THE ARGININE VASOPRESSIN V2 RECEPTOR CAUSES NEPHROGENIC DIABETES INSIPIDUS
Abstract
Background: Nephrogenic diabetes insipidus (NDI) is a disease characterized by a defective response to the antidiuretic hormone (ADH) of the renal collecting duct leading to a decline in the ability of the pro-urine concentration.
Case presentation: A 23-year-old man presented with an over 20-year history of polyuria concomitant with hydronephrosis. The diagnosis of NDI was established by gene analysis as well as a water-deprivation and vasopressin test. All exons of arginine vasopressin V2 receptor (AVPR2) gene were amplified and sequenced. A novel hemizygous intragenic inframe deletion, cDNA 255th bp to 263th bp in exon 2 of AVPR2, was identified. These relevant translations from the 85th amino acid Asp to 88th amino acid Val were missed and replaced by amino acid Glu. After treating the patient with hydrochlorothiazide, his symptoms improved significantly.
Conclusion: The genetic analysis revealed a novel X-linked intragenic inframe deletion, AVPR2 gene cDNA 255th bp to 263th bp, causing NDI.
Keywords: Nephrogenic diabetes insipidus; arginine vasopressin V2 receptor; intragenic inframe deletion; polyuria.
©by Acta Endocrinologica Foundation.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures

Similar articles
-
A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.Endocrine. 2014 May;46(1):148-53. doi: 10.1007/s12020-013-0043-7. Epub 2013 Sep 13. Endocrine. 2014. PMID: 24026507
-
A Novel Mutation in the AVPR2 Gene Causing Congenital Nephrogenic Diabetes Insipidus.J Clin Res Pediatr Endocrinol. 2018 Nov 29;10(4):350-356. doi: 10.4274/jcrpe.0097. Epub 2018 Jul 11. J Clin Res Pediatr Endocrinol. 2018. PMID: 29991464 Free PMC article.
-
Partial nephrogenic diabetes insipidus with a novel arginine vasopressin receptor 2 gene variant.Clin Pediatr Endocrinol. 2022;31(1):44-49. doi: 10.1297/cpe.2021-0029. Epub 2021 Nov 1. Clin Pediatr Endocrinol. 2022. PMID: 35002068 Free PMC article.
-
Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).Best Pract Res Clin Endocrinol Metab. 2016 Mar;30(2):263-76. doi: 10.1016/j.beem.2016.02.010. Epub 2016 Mar 2. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27156763 Review.
-
Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.Int J Mol Sci. 2017 Nov 10;18(11):2385. doi: 10.3390/ijms18112385. Int J Mol Sci. 2017. PMID: 29125546 Free PMC article. Review.
References
-
- Di Iorgi N, Napoli F, Allegri AE, Olivieri I, Bertelli E, Gallizia A, Rossi A, Maghnie M. Diabetes insipidus - diagnosis and management. Horm Res Paediatr. 2012;77(2):69–84. - PubMed
-
- Kavanagh C, Uy NS. Nephrogenic Diabetes Insipidus. Pediatr Clin North Am. 2019;66(1):227–234. - PubMed
-
- Sasaki S, Chiga M, Kikuchi E, Rai T, Uchida S. Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutation deletions in AVPR2 and AQP2. Clinical & Experimental Nephrology. 2013;17(3):338–344. - PubMed
-
- Juul KV, Bichet DG, Nielsen S, Nørgaard JP. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Am J Physiol Renal Physiol. 2014;306(9):931–940. - PubMed
-
- Bichet DG, Bockenhauer D. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant) Best Practice & Research Clinical Endocrinology & Metabolism. 2016;30(2):263–276. - PubMed
LinkOut - more resources
Full Text Sources